| abstract |
A preventive and/or therapeutic agent for sinusitis, nasal congestion, hyperemia of the nasal mucosa, asthma and the like containing, N-{2-[2-[(3-fluorophenyl)imino]-4-(4-morpholine-4-ylphenyl)-1,3-thiazole-3(2H)-yl]ethyl}-N'-methylurea represented by the formula (1) or a pharmaceutically acceptable salt thereof as an active ingredient. |